Infective endocarditis: a case series
Main Article Content
Keywords
infective endocarditis, valve replacement, valve vegetation
Abstract
Introduction: Infective endocarditis (IE) remains a critical cardiovascular condition with significant mortality rates, ranging from 20% during hospitalization to 25-30% within six months post-infection. Valve abnormalities have been strongly associated with IE and worsen patient symptoms and prognostic. This study presents a case series of IE in Dr. Mohammad Hoesin Palembang Hospital.
Case presentations: This case series reports on the management and outcomes of four pediatric patients treated for IE between January and May 2024 in RSUP Mohammad Hoesin Palembang. Each patient presents with moderate to severe mitral regurgitation and valve vegetation. Diagnoses were based on clinical symptoms and echocardiographic findings, adhering to the Duke criteria. The management involved systemic antibiotics and valve replacement surgery, with a focus on individualized treatment plans based on the severity of regurgitation and the presence of vegetation. Notably, all four patients survived and demonstrated substantial improvement in quality of life after surgical management.
Conclusions: Our findings emphasize the efficacy of a multidisciplinary approach combining antibiotic therapy with timely surgical intervention for successful treatment outcomes in IE. Early diagnosis and appropriate management, including valve replacement, when necessary, are crucial for improving patient survival and quality of life.
References
2. Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S 1998-2009: a nationwide study. PLoS One. 2013;8(3): e60033
3. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med. 2012;172(4):363–5
4. Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet 2015;385(9974) :1219–28
5. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162(1):90–4
6. Math RS, Sharma G, Kothari SS, et al. Prospective study of infective endocarditis from a developing country. Am Heart J. 2011;162(4):633–638
7. Garg N, Kandpal B, Garg N, et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992-2001. Int J Cardiol. 2005;98(2):253–60
8. Baddour LM, Wilson WR, et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86. Selton-Suty
9. C, Célard M, Le Moing V, et al; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9
10. Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40(5):527–35
11. Nadji G, Rusinaru D, Rémadi JP, Jeu A, Sorel C, Tribouilloy C. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11(7):668–75
12. Olmos C, Vilacosta I, Fernández C, et al. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J. 2013;34(26):1999–2006
13. García-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious DiseasesSpanish Network for Research in Infectious Diseases. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127(23):2272–84
14. Tattevin P, Revest M, Lefort A, Michelet C, Lortholary O. Fungal endocarditis: current challenges. Int J Antimicrob Agents. 2014;44(4):290-4
15. Smego RA Jr, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore). 2011;90(4):237–49
16. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32(16):2027–33
17. Hoen B, Alla F, Selton-Suty C, et al; Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75–81
18. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368(15):1425–33
19. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91(5):571–75
20. Robert S. Baltimore, MD, Michael Gewitz, MD, et al. Infective endocarditis in Childhood: 2015 update: A scientific statement from American Heart Association. Circulation. 2015;132(15):1487-515
21. San Román JA, López J, Vilacosta I, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120(4):369.e1-7
22. Habib G, Lancellotti P, Antunes MJ, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128
23. Baddour LM, Wilson WR, Bayer AS, et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86
24. Pettersson GB, Hussain ST, Coselli JS, et al. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg. 2019;8(6):630–44